MedTrace Logo

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

NCT03308643 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-05-21

No results posted yet for this study

Summary

To evaluate the effects of oxytocin infusion during abdominal myomectomy.

Conditions

  • Myomectomy

Interventions

DRUG

Oxytocin

Patients will receive intravenous oxytocin infusion just before the surgery after the induction of general anesthesia.

OTHER

saline

Patients will receive intravenous normal saline infusion just before the surgery after the induction of general anesthesia.

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Principal Investigators

  • Berna Aslan · Kanuni Sultan Suleyman Research and Training Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-05-10
Completion
2018-05-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03308643 on ClinicalTrials.gov